MetaVia Inc. · CIK 1638287
MetaVia Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
May 15, 2025
through May 15, 2025
through May 15, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $10,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $10,000,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Akari Therapeutics Plc · CIK 1541157
- Dare Bioscience, Inc. · CIK 1401914
- DATA I/O CORP · CIK 351998
- INTELLIGENT BIO SOLUTIONS INC. · CIK 1725430
- Peraso Inc. · CIK 890394
Form D filings (1)
-
0001104659-25-049376D · May 15, 2025 · BiotechnologyOffering: $10,000,000Sold: $10,000,000